Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Theuretzbacher

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2012
Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancerUrsula Theuretzbacher
Current Opinion in Microbiology|November 21, 2017
Global antimicrobial resistance in Gram-negative pathogens and clinical needUrsula Theuretzbacher
Pharmazie in Unserer Zeit|October 3, 2006
[The opponent, we were unable to defeat. Beta-lactamases]Ursula Theuretzbacher
Current Opinion in Pharmacology|August 25, 2011
Resistance drives antibacterial drug developmentUrsula Theuretzbacher
International Journal of Antimicrobial Agents|April 4, 2009
Future antibiotics scenarios: is the tide starting to turn?Ursula Theuretzbacher
Current Opinion in Pharmacology|July 10, 2007
Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?Ursula Theuretzbacher
Nature Microbiology|July 26, 2020
Dual-mechanism antibioticsUrsula Theuretzbacher
Nature Reviews. Microbiology|September 13, 2024
Challenges and strategies for addressing antibacterial drug resistance in LMICsUrsula Theuretzbacher
International Journal of Antimicrobial Agents|February 21, 2012
Accelerating resistance, inadequate antibacterial drug pipelines and international responsesUrsula Theuretzbacher
The Journal of Antimicrobial Chemotherapy|March 18, 2014
Product information for parenteral colistin varies substantially across EuropeUrsula Theuretzbacher
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2012
Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancerUrsula Theuretzbacher
Current Opinion in Microbiology|November 21, 2017
Global antimicrobial resistance in Gram-negative pathogens and clinical needUrsula Theuretzbacher
Pharmazie in Unserer Zeit|October 3, 2006
[The opponent, we were unable to defeat. Beta-lactamases]Ursula Theuretzbacher
Current Opinion in Pharmacology|August 25, 2011
Resistance drives antibacterial drug developmentUrsula Theuretzbacher
International Journal of Antimicrobial Agents|April 4, 2009
Future antibiotics scenarios: is the tide starting to turn?Ursula Theuretzbacher
Current Opinion in Pharmacology|July 10, 2007
Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?Ursula Theuretzbacher
Nature Microbiology|July 26, 2020
Dual-mechanism antibioticsUrsula Theuretzbacher
Nature Reviews. Microbiology|September 13, 2024
Challenges and strategies for addressing antibacterial drug resistance in LMICsUrsula Theuretzbacher
International Journal of Antimicrobial Agents|February 21, 2012
Accelerating resistance, inadequate antibacterial drug pipelines and international responsesUrsula Theuretzbacher
The Journal of Antimicrobial Chemotherapy|March 18, 2014
Product information for parenteral colistin varies substantially across EuropeUrsula Theuretzbacher
Pageof 7